Crossref
Meeting report: Advances in minimal residual disease testing in multiple myeloma 2018
Advances in Cell and Gene Therapy · 2019
DOI: 10.1002/acg2.26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Cell and Gene Therapy, 2019. Verfasst von Ola Landgren und 1 weiteren Autor:innen. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Memorial Sloan Kettering Core.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Memorial Sloan Kettering Core
Zitieren
APA
Landgren, O., & Rustad, E. H. (2019). Meeting report: Advances in minimal residual disease testing in multiple myeloma 2018. Advances in Cell and Gene Therapy. https://doi.org/10.1002/acg2.26
Vancouver
Landgren O, Rustad EH. Meeting report: Advances in minimal residual disease testing in multiple myeloma 2018. Advances in Cell and Gene Therapy. 2019. doi:10.1002/acg2.26
BibTeX
@article{Landgren2019,
author = {Landgren, Ola and Rustad, Even H.},
title = {Meeting report: Advances in minimal residual disease testing in multiple myeloma 2018},
journal = {Advances in Cell and Gene Therapy},
year = {2019},
doi = {10.1002/acg2.26}
}
EUVIMED